1807512-41-9

Usage

Uses

Used in Pharmaceutical Industry:
1,1,1-Trifluoroethyl-PEG5-Alcohol is used as a conjugation agent for enhancing the stability and solubility of therapeutic proteins and peptides. The trifluoroethyl group can form stable covalent bonds with primary amine groups, improving the pharmacokinetic properties and reducing the immunogenicity of the conjugated molecules.
Used in Drug Delivery Systems:
In the field of drug delivery, 1,1,1-Trifluoroethyl-PEG5-Alcohol is utilized as a component in the design of targeted drug delivery systems. The ability of the trifluoroethyl group to react with amine-containing molecules allows for the specific attachment of drug molecules or targeting ligands to the PEG linker, enabling selective delivery to desired sites within the body and reducing off-target effects.
Used in Diagnostics and Imaging:
1,1,1-Trifluoroethyl-PEG5-Alcohol is used as a contrast agent or a component in the development of imaging probes. The PEG linker can improve the biocompatibility and circulation time of imaging agents, while the trifluoroethyl group can be used to attach imaging moieties or targeting ligands to enhance the specificity and sensitivity of diagnostic procedures.
Used in Surface Modification:
In the context of surface modification, 1,1,1-Trifluoroethyl-PEG5-Alcohol is employed as a functionalizing agent to introduce specific chemical functionalities or bioactive molecules onto various surfaces, such as implants, sensors, or lab-on-a-chip devices. The trifluoroethyl group can be used to immobilize proteins, antibodies, or other biomolecules, while the PEG linker provides a hydrophilic and biocompatible environment that can reduce non-specific interactions and fouling.
Used in Material Science:
1,1,1-Trifluoroethyl-PEG5-Alcohol is used as a building block in the synthesis of novel materials with tailored properties. The compound can be incorporated into polymers, dendrimers, or other macromolecular structures to impart specific characteristics, such as enhanced solubility, improved biocompatibility, or controlled release of active agents.